Search





Search





Quince Therapeutics Inc

QNCX

Add to Watchlist

34.040USD

+1.630+5.03%

Close 08-14 16:00（ET）Quotes delayed by 15 min

34.62MMarket Cap

1.50P/E TTM

Quince Therapeutics Inc

34.040

+1.630+5.03%

Financial Summary Income Statement Balance Sheet Cash Flow Statement Earnings Company Valuation Risk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial Summary Income Statement Balance Sheet Cash Flow Statement Earnings Company Valuation Risk Assessment

QNCX Cash Flow Statement

You can access the annual and quarterly cash flow statements of Quince Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q3

FY2018Q2

FY2018Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-65.46%-18.89M

20.56%-7.63M

-38.78%-10.48M

-36.75%-9.93M

-30.62%-11.41M

-14.94%-9.60M

-24.25%-7.55M

-50.68%-7.26M

-128.35%-8.74M

-134.04%-8.35M

-4.16%-6.08M

28.06%-4.82M

75.17%-3.83M

77.82%-3.57M

59.53%-5.83M

61.38%-6.70M

12.23%-15.41M

-18.23%-16.09M

-8.60%-14.42M

-40.18%-17.34M

-22.03%-17.56M

-26.26%-13.61M

-21.24%-13.28M

-40.64%-12.37M

-127.90%-14.39M

-49.38%-10.78M

---10.95M

-356.94%-8.80M

-141.03%-6.32M

-127.13%-7.22M

---1.93M

---2.62M

---3.18M

Net income from continuing operations

-370.36%-75.49M

338.94%35.91M

-216.73%-39.46M

-144.76%-13.44M

42.12%-16.05M

-34.81%-15.03M

-40.07%-12.46M

-2.64%-5.49M

-467.52%-27.73M

9.02%-11.15M

-60.72%-8.89M

32.45%-5.35M

70.50%-4.89M

43.38%-12.25M

76.35%-5.53M

63.51%-7.92M

23.86%-16.56M

6.26%-21.64M

-13.84%-23.40M

-0.93%-21.71M

-23.52%-21.75M

-34.41%-23.09M

-66.05%-20.55M

-118.16%-21.51M

-94.35%-17.61M

-202.34%-17.18M

---12.38M

-291.04%-9.86M

-191.57%-9.06M

-68.23%-5.68M

---2.52M

---3.11M

---3.38M

Operating gains losses

17.14%41.00K

211912.50%67.84M

143.75%39.00K

-58.14%36.00K

-99.80%35.00K

-20.00%32.00K

-94.74%16.00K

--86.00K

1717300.00%17.17M

-99.33%40.00K

623.81%304.00K

-100.00%0.00

-99.45%1.00K

15644.74%5.98M

-50.00%42.00K

937.93%903.00K

109.20%182.00K

-55.81%38.00K

-1.18%84.00K

3.57%87.00K

8.75%87.00K

3.61%86.00K

11.84%85.00K

42.37%84.00K

135.29%80.00K

336.84%83.00K

--76.00K

490.00%59.00K

277.78%34.00K

137.50%19.00K

--10.00K

--9.00K

--8.00K

Deferred tax

----

---4.96M

----

--0.00

100.00%0.00

--0.00

100.00%0.00

---248.00K

--0.00

---284.00K

----

Other non-cash items

24167.66%56.56M

-645.35%-2.65M

-35.71%-665.00K

60.14%-236.00K

62.10%-235.00K

45.05%-355.00K

30.59%-490.00K

16.74%-592.00K

-33.91%-620.00K

-364.75%-646.00K

-213.78%-706.00K

-672.83%-711.00K

-1257.50%-463.00K

-202.96%-139.00K

-213.07%-225.00K

-137.10%-92.00K

-88.10%40.00K

-54.08%135.00K

-33.22%199.00K

-15.07%248.00K

27.27%336.00K

98.65%294.00K

3625.00%298.00K

220.66%292.00K

300.00%264.00K

287.34%148.00K

--8.00K

-296.72%-242.00K

-151.97%-132.00K

-117.95%-79.00K

---61.00K

--254.00K

--440.00K

Change in working capital

-305.18%-7.58M

-216.04%-2.38M

558.05%12.47M

227.63%194.00K

-31.65%-1.87M

354.78%2.05M

777.31%1.90M

-74.71%-152.00K

-786.96%-1.42M

-147.97%-805.00K

112.34%216.00K

69.04%-87.00K

105.39%207.00K

143.44%1.68M

-953.66%-1.75M

92.17%-281.00K

-28.85%-3.84M

-283.52%-3.86M

-89.42%205.00K

-178.03%-3.59M

-471.07%-2.98M

-50.01%2.10M

152.21%1.94M

1281.68%4.60M

-121.15%-522.00K

352.91%4.21M

--768.00K

-46.89%333.00K

3185.00%2.47M

-280.14%-1.67M

--627.00K

---80.00K

---438.00K

-Change in prepaid expenses

201.69%362.00K

-485.49%-3.64M

773.57%2.74M

-2300.00%-374.00K

77.78%-356.00K

314.55%944.00K

-84.09%314.00K

103.84%17.00K

-223.04%-1.60M

-131.14%-440.00K

972.83%1.97M

-168.58%-443.00K

-23.77%1.30M

3264.29%1.41M

27.78%184.00K

-26.42%646.00K

156.13%1.71M

-96.48%42.00K

-87.37%144.00K

-54.37%878.00K

-227.56%-3.04M

2332.65%1.19M

155.80%1.14M

55.92%1.92M

-4.74%-929.00K

101.35%49.00K

---2.04M

332.98%1.23M

-379.46%-887.00K

-4435.00%-3.63M

--285.00K

---185.00K

---80.00K

-Change in other current assets

97.18%-8.00K

993.25%1.78M

1171.49%4.81M

-179.31%-486.00K

-158.18%-284.00K

2137.50%163.00K

-944.19%-449.00K

-2075.00%-174.00K

-1933.33%-110.00K

-110.96%-8.00K

-219.44%-43.00K

-128.57%-8.00K

-89.83%6.00K

-55.76%73.00K

3700.00%36.00K

158.33%28.00K

155.66%59.00K

--165.00K

-100.59%-1.00K

-237.14%-48.00K

-292.59%-106.00K

----

269.57%170.00K

1266.67%35.00K

---27.00K

----

--46.00K

---3.00K

--0.00

---250.00K

--0.00

-Change in other current liabilities

---688.00K

--701.00K

--742.00K

----

Cash from non-recurring investing activities

Cash from operating activities

-65.46%-18.89M

20.56%-7.63M

-38.78%-10.48M

-36.75%-9.93M

-30.62%-11.41M

-14.94%-9.60M

-24.25%-7.55M

-50.68%-7.26M

-128.35%-8.74M

-134.04%-8.35M

-4.16%-6.08M

28.06%-4.82M

75.17%-3.83M

77.82%-3.57M

59.53%-5.83M

61.38%-6.70M

12.23%-15.41M

-18.23%-16.09M

-8.60%-14.42M

-40.18%-17.34M

-22.03%-17.56M

-26.26%-13.61M

-21.24%-13.28M

-40.64%-12.37M

-127.90%-14.39M

-49.38%-10.78M

---10.95M

-356.94%-8.80M

-141.03%-6.32M

-127.13%-7.22M

---1.93M

---2.62M

---3.18M

Investing cash flow

Net cash from continuing investing activities

-100.00%0.00

-96.99%4.00K

60.87%74.00K

223.08%126.00K

279.49%148.00K

454.17%133.00K

--46.00K

--39.00K

-71.32%39.00K

-69.23%24.00K

-100.00%0.00

--0.00

2620.00%136.00K

77.27%78.00K

--50.00K

-100.00%0.00

-86.49%5.00K

340.00%44.00K

-100.00%0.00

482.35%99.00K

640.00%37.00K

11.11%10.00K

-23.08%20.00K

154.84%17.00K

-90.20%5.00K

--9.00K

-86.87%26.00K

-321.43%-31.00K

--51.00K

--198.00K

--14.00K

--0.00

Capital expenditures

-100.00%0.00

-96.99%4.00K

60.87%74.00K

223.08%126.00K

279.49%148.00K

454.17%133.00K

--46.00K

--39.00K

-71.32%39.00K

-69.23%24.00K

-100.00%0.00

--0.00

2620.00%136.00K

77.27%78.00K

--50.00K

-100.00%0.00

-86.49%5.00K

340.00%44.00K

-100.00%0.00

482.35%99.00K

640.00%37.00K

11.11%10.00K

-23.08%20.00K

--17.00K

-90.20%5.00K

--9.00K

-86.87%26.00K

----

--51.00K

--198.00K

--14.00K

--0.00

Net cash flow from disposal of fixed assets

-100.00%0.00

-96.99%4.00K

60.87%74.00K

223.08%126.00K

279.49%148.00K

454.17%133.00K

--46.00K

--39.00K

-71.32%39.00K

-69.23%24.00K

-100.00%0.00

--0.00

2620.00%136.00K

77.27%78.00K

--50.00K

-100.00%0.00

-86.49%5.00K

340.00%44.00K

-100.00%0.00

482.35%99.00K

640.00%37.00K

11.11%10.00K

-23.08%20.00K

154.84%17.00K

-90.20%5.00K

--9.00K

-86.87%26.00K

-321.43%-31.00K

--51.00K

--198.00K

--14.00K

--0.00

Net cash flow from business transactions

----

---2.12M

----

Net cash flow from investment products

-100.00%0.00

8.64%12.00M

-26.59%8.07M

-123.87%-1.71M

224.82%6.17M

23.38%11.05M

36.99%11.00M

72.94%7.15M

75.70%-4.94M

60.28%8.95M

-57.16%8.03M

146.93%4.13M

-27.99%-20.32M

-58.37%5.59M

-10.59%18.74M

-1250.26%-8.81M

-377.46%-15.88M

-57.65%13.42M

32.38%20.96M

-92.63%766.00K

196.51%5.72M

143.59%31.68M

-10.60%15.84M

12.36%10.39M

87.61%-5.93M

-2360.53%-72.68M

--17.71M

119.23%9.25M

---47.87M

--3.21M

---48.10M

--0.00

Net cash flow from other investing activities

--8.00M

--0.00

----

100.00%0.00

--0.00

-100.00%0.00

---500.00K

-1528.57%-500.00K

-100.00%0.00

--90.00K

--0.00

--35.00K

--10.63M

----

Cash from non-current investing activities

Net cash flow from investing activities

32.49%8.00M

10.11%12.00M

-25.73%8.07M

-125.07%-1.78M

221.31%6.04M

22.26%10.90M

101.61%10.87M

95.46%7.11M

75.51%-4.98M

60.90%8.91M

-71.12%5.39M

141.19%3.63M

-287.03%-20.32M

-58.70%5.54M

-10.77%18.67M

-1252.22%-8.83M

-193.37%-5.25M

-57.61%13.41M

32.18%20.92M

-92.61%766.00K

194.57%5.62M

143.54%31.64M

-10.61%15.83M

12.46%10.37M

87.57%-5.95M

-2397.12%-72.68M

--17.70M

119.09%9.22M

-341592.86%-47.84M

--3.16M

---48.30M

---14.00K

--0.00

Financing cash flow

Cash flow from continuous financing activities

655.85%108.93M

10754.02%9.44M

--2.03M

127.52%1.38M

41077.14%14.41M

-54.21%87.00K

-100.00%0.00

-50100.00%-5.00M

34.62%35.00K

280.00%190.00K

416.67%57.00K

300.00%10.00K

-75.93%26.00K

-91.96%50.00K

-101.82%-18.00K

-100.11%-5.00K

-83.93%108.00K

41.04%622.00K

2100.00%990.00K

5127.78%4.71M

-24.41%672.00K

-99.63%441.00K

108.49%45.00K

--90.00K

-98.86%889.00K

184043.75%117.85M

---530.00K

--0.00

2.82%77.83M

-73.11%64.00K

--0.00

--75.70M

--238.00K

Net cash flow from debt Issuance/repayment

--0.00

---5.54M

----

--0.00

100.00%0.00

---6.00K

---18.00K

---19.00K

---12.00K

----

100.00%0.00

--0.00

----

99.64%-2.00K

--0.00

---3.00K

---29.00K

---559.00K

--0.00

-100.00%0.00

--0.00

--250.00K

Net cash flow from common stock issuance/repurchase

-62.63%5.35M

--14.99M

--2.00M

--1.38M

--14.32M

----

--0.00

-100.00%0.00

--0.00

--608.00K

--0.00

----

--0.00

-100.08%-62.00K

--117.69M

--0.00

648458.33%77.83M

100.00%0.00

--0.00

--12.00K

---12.00K

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-100.00%0.00

----

--0.00

--75.69M

----

Proceeds from stock option exercised by employees

-100.00%0.00

--37.00K

--0.00

174.29%96.00K

-54.21%87.00K

-100.00%0.00

34.62%35.00K

239.29%190.00K

--57.00K

-28.57%10.00K

-78.33%26.00K

300.00%56.00K

-100.00%0.00

-99.70%14.00K

-82.14%120.00K

-96.83%14.00K

2006.38%990.00K

5127.78%4.71M

-29.56%672.00K

130.89%441.00K

67.86%47.00K

--90.00K

18980.00%954.00K

198.44%191.00K

--28.00K

--0.00

--5.00K

--64.00K

--0.00

Proceeds from issuance of warrants

---56.00K

----

--1.00K

----

Net cash flow from other financing activities

--103.64M

--0.00

100.00%0.00

----

--0.00

---5.00M

----

Net cash from non-recurrent financing activities

Net cash from financing activities

655.85%108.93M

10754.02%9.44M

--2.03M

127.52%1.38M

41077.14%14.41M

-54.21%87.00K

-100.00%0.00

-50100.00%-5.00M

34.62%35.00K

280.00%190.00K

416.67%57.00K

300.00%10.00K

-75.93%26.00K

-91.96%50.00K

-101.82%-18.00K

-100.11%-5.00K

-83.93%108.00K

41.04%622.00K

2100.00%990.00K

5127.78%4.71M

-24.41%672.00K

-99.63%441.00K

108.49%45.00K

--90.00K

-98.86%889.00K

184043.75%117.85M

---530.00K

--0.00

2.82%77.83M

-73.11%64.00K

--0.00

--75.70M

--238.00K

Net cash flow

Beginning cash balance

----

-6.49%5.81M

141.20%6.45M

113.26%16.83M

-64.37%7.77M

-70.07%6.21M

-87.63%2.67M

-65.17%7.89M

-53.31%21.81M

-53.45%20.75M

-31.99%21.63M

-51.73%22.65M

-30.86%46.71M

-36.06%44.58M

-48.87%31.81M

-36.63%46.93M

-20.81%67.56M

4.31%69.72M

-3.17%62.21M

11.93%74.05M

-0.34%85.31M

30.51%66.84M

42.80%64.25M

48.45%66.16M

309.91%85.61M

105.91%51.21M

--44.99M

-42.51%44.56M

368.88%20.88M

236.43%24.87M

--77.52M

--4.45M

--7.39M

Current period cash flow changes

980.27%97.82M

692.43%12.35M

-118.18%-643.00K

-98.93%-10.37M

165.04%9.05M

46.94%1.56M

501.93%3.54M

-412.28%-5.21M

42.14%-13.92M

-50.30%1.06M

-106.89%-880.00K

93.27%-1.02M

-16.61%-24.06M

198.84%2.13M

69.88%12.77M

-27.67%-15.12M

-83.17%-20.64M

-111.69%-2.16M

189.67%7.52M

-520.00%-11.84M

42.08%-11.27M

-46.28%18.47M

-58.31%2.59M

-548.36%-1.91M

-182.14%-19.45M

962.39%34.39M

--6.22M

100.85%426.00K

-67.59%23.68M

-35.69%-3.99M

---50.23M

--73.07M

---2.94M

Effect of exchange rate changes

-1305.26%-229.00K

-935.43%-1.46M

-220.27%-267.00K

31.67%-41.00K

107.88%19.00K

-43.55%175.00K

189.16%222.00K

-138.71%-60.00K

-501.67%-241.00K

171.93%310.00K

-479.07%-249.00K

-62.10%155.00K

176.92%60.00K

209.62%114.00K

-265.38%-43.00K

1310.34%409.00K

---78.00K

---104.00K

--26.00K

--29.00K

----

Ending cash balance

589.30%115.98M

133.73%18.16M

-6.49%5.81M

141.20%6.45M

113.26%16.83M

-64.37%7.77M

-70.07%6.21M

-87.63%2.67M

-65.17%7.89M

-53.31%21.81M

-53.45%20.75M

-31.99%21.63M

-51.73%22.65M

-30.86%46.71M

-36.06%44.58M

-48.87%31.81M

-36.63%46.93M

-20.81%67.56M

4.31%69.72M

-3.17%62.21M

11.93%74.05M

-0.34%85.31M

30.51%66.84M

42.80%64.25M

48.45%66.16M

309.91%85.61M

--51.21M

64.83%44.99M

-42.51%44.56M

368.88%20.88M

--27.29M

--77.52M

--4.45M

Free cash flow

-63.65%-18.89M

21.77%-7.63M

-36.43%-10.48M

-36.90%-10.00M

-31.48%-11.54M

-16.17%-9.75M

-25.94%-7.69M

-51.64%-7.31M

-129.37%-8.78M

-126.50%-8.39M

-3.20%-6.10M

28.59%-4.82M

75.17%-3.83M

76.98%-3.71M

59.11%-5.91M

61.09%-6.75M

12.72%-15.41M

-17.95%-16.10M

-8.85%-14.46M

-39.96%-17.34M

-22.57%-17.66M

-26.55%-13.65M

-21.23%-13.29M

-40.46%-12.39M

---14.41M

-48.40%-10.78M

---10.96M

-315.54%-8.82M

----

-128.74%-7.27M

---2.12M

---2.63M

---3.18M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Quince Therapeutics Inc Generate?



Quince Therapeutics Inc generated -41.42M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Quince Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Quince Therapeutics Inc's operating cash flow increased by -29.84% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Quince Therapeutics Inc Spend on Capital Expenditures?



Quince Therapeutics Inc spent 352.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Quince Therapeutics Inc's Financing Cash Flow Changed?



Quince Therapeutics Inc used 17.91M in financing activities in the latest quarter.

What is free cash flow and why does it matter for QNCX?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Quince Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -41.78M reflecting a -29.90% change from the previous year.